Your browser doesn't support javascript.
loading
Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism.
Wang, Fenglin; Xie, Min; Chen, Pan; Wang, Dan; Yang, Minghua.
Afiliação
  • Wang F; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
  • Xie M; Hunan Clinical Research Center of Pediatric Cancer, Changsha 410013, Hunan, China.
  • Chen P; Department of Pediatrics, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Wang D; Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Yang M; Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Oxid Med Cell Longev ; 2022: 8212286, 2022.
Article em En | MEDLINE | ID: mdl-35873796
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Aclarubicina / Leucemia Mieloide Aguda / Cladribina / Mepesuccinato de Omacetaxina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Oxid Med Cell Longev Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Aclarubicina / Leucemia Mieloide Aguda / Cladribina / Mepesuccinato de Omacetaxina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Oxid Med Cell Longev Ano de publicação: 2022 Tipo de documento: Article